Ann Eshenaur Spolarich, RDH, PhD, FSCDH, is a professor, course director of clinical medicine and pharmacology, and director of research at the Arizona School of Dentistry & Oral Health (ASDOH), A.T. Still University in Mesa, where she also teaches part-time in the Special Care Dentistry Clinic. Spolarich is a member of Dimensions of Dental Hygiene’s Editorial Advisory Board. She can be reached at: anneshspo@aol.com.
While advancements in science and technology are transforming the face of dental hygiene practice, the patient populations seeking oral care services are also undergoing significant change.
Dental hygienists can serve as advocates for their patients with autoimmune diseases—from detecting immune system dysfunction to providing safe and effective treatment.
With obesity linked to the inflammatory process and the significant growth of obesity and overweight across the globe, dental hygienists need to understand the implications.
Dental hygienists need to understand the possible negative effects on the oral cavity caused by medication use in order to provide the best care to patients.